ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
philby
|
2.1K |
675K |
0 |
23/01/23 |
23/01/23 |
ASX - By Stock
|
2.1K
|
675K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
philby
|
2.1K |
675K |
0 |
23/01/23 |
23/01/23 |
ASX - By Stock
|
2.1K
|
675K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
philby
|
2.1K |
675K |
0 |
21/01/23 |
21/01/23 |
ASX - By Stock
|
2.1K
|
675K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
philby
|
2.1K |
675K |
0 |
20/01/23 |
20/01/23 |
ASX - By Stock
|
2.1K
|
675K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
philby
|
2.1K |
675K |
8 |
20/01/23 |
20/01/23 |
ASX - By Stock
|
2.1K
|
675K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Letter to Shareholders, Notice of AGM & Proxy Form
|
|
philby
|
52 |
8.2K |
3 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
52
|
8.2K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Annual Report to Shareholders
|
|
philby
|
29 |
5.0K |
5 |
24/10/22 |
24/10/22 |
ASX - By Stock
|
29
|
5.0K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
philby
|
2.1K |
675K |
5 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
2.1K
|
675K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
philby
|
2.1K |
675K |
16 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
2.1K
|
675K
|
16
|
|
ASX - By Stock
|
CYP |
Re:
price query 19th july 2019
|
|
philby
|
5 |
1.4K |
2 |
14/10/22 |
14/10/22 |
ASX - By Stock
|
5
|
1.4K
|
2
|
|
ASX - By Stock
|
CYP |
price query 19th july 2019
|
|
philby
|
5 |
1.4K |
3 |
14/10/22 |
14/10/22 |
ASX - By Stock
|
5
|
1.4K
|
3
|
|
ASX - By Stock
|
CYP |
Dross
|
|
philby
|
6 |
1.8K |
6 |
13/10/22 |
13/10/22 |
ASX - By Stock
|
6
|
1.8K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Successful Completion of Planned DSMB Review of DFU Trial
|
|
philby
|
48 |
12K |
8 |
12/10/22 |
12/10/22 |
ASX - By Stock
|
48
|
12K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
who is running our Social Media
|
|
philby
|
4 |
1.1K |
0 |
11/10/22 |
11/10/22 |
ASX - By Stock
|
4
|
1.1K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
who is running our Social Media
|
|
philby
|
4 |
1.1K |
3 |
11/10/22 |
11/10/22 |
ASX - By Stock
|
4
|
1.1K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Commences DFU Clinical Trial
|
|
philby
|
57 |
14K |
6 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
57
|
14K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Grant Award to Fund Study of Cynata MSCs in Heart Disease
|
|
philby
|
53 |
11K |
1 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
53
|
11K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Grant Award to Fund Study of Cynata MSCs in Heart Disease
|
|
philby
|
53 |
11K |
7 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
53
|
11K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Grant Award to Fund Study of Cynata MSCs in Heart Disease
|
|
philby
|
53 |
11K |
10 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
53
|
11K
|
10
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Grant Award to Fund Study of Cynata MSCs in Heart Disease
|
|
philby
|
53 |
11K |
1 |
30/09/22 |
30/09/22 |
ASX - By Stock
|
53
|
11K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Grant Award to Fund Study of Cynata MSCs in Heart Disease
|
|
philby
|
53 |
11K |
4 |
30/09/22 |
30/09/22 |
ASX - By Stock
|
53
|
11K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Grant Award to Fund Study of Cynata MSCs in Heart Disease
|
|
philby
|
53 |
11K |
9 |
30/09/22 |
30/09/22 |
ASX - By Stock
|
53
|
11K
|
9
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Grant Award to Fund Study of Cynata MSCs in Heart Disease
|
|
philby
|
53 |
11K |
1 |
30/09/22 |
30/09/22 |
ASX - By Stock
|
53
|
11K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Grant Award to Fund Study of Cynata MSCs in Heart Disease
|
|
philby
|
53 |
11K |
1 |
29/09/22 |
29/09/22 |
ASX - By Stock
|
53
|
11K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Grant Award to Fund Study of Cynata MSCs in Heart Disease
|
|
philby
|
53 |
11K |
11 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
53
|
11K
|
11
|
|
ASX - By Stock
|
CYP |
Re:
1.9 billion for chronic gvhd acquisition
|
|
philby
|
4 |
1.1K |
8 |
27/09/22 |
27/09/22 |
ASX - By Stock
|
4
|
1.1K
|
8
|
|
ASX - By Stock
|
CYP |
who is running our Social Media
|
|
philby
|
4 |
1.1K |
3 |
27/09/22 |
27/09/22 |
ASX - By Stock
|
4
|
1.1K
|
3
|
|
ASX - By Stock
|
CYP |
1.9 billion for chronic gvhd acquisition
|
|
philby
|
4 |
1.1K |
8 |
26/09/22 |
26/09/22 |
ASX - By Stock
|
4
|
1.1K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
warf licence
|
|
philby
|
24 |
5.6K |
2 |
26/09/22 |
26/09/22 |
ASX - By Stock
|
24
|
5.6K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
warf licence
|
|
philby
|
24 |
5.6K |
6 |
17/09/22 |
17/09/22 |
ASX - By Stock
|
24
|
5.6K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
warf licence
|
|
philby
|
24 |
5.6K |
10 |
16/09/22 |
16/09/22 |
ASX - By Stock
|
24
|
5.6K
|
10
|
|
ASX - By Stock
|
CYP |
Re:
warf licence
|
|
philby
|
24 |
5.6K |
0 |
16/09/22 |
16/09/22 |
ASX - By Stock
|
24
|
5.6K
|
0
|
|
ASX - By Stock
|
CYP |
warf licence
|
|
philby
|
24 |
5.6K |
11 |
16/09/22 |
16/09/22 |
ASX - By Stock
|
24
|
5.6K
|
11
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Appointment of Ms Janine Rolfe to the Cynata Board
|
|
philby
|
37 |
9.1K |
7 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
37
|
9.1K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Appointment of Ms Janine Rolfe to the Cynata Board
|
|
philby
|
37 |
9.1K |
6 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
37
|
9.1K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Appendix 4E & Annual Report
|
|
philby
|
54 |
10K |
2 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
54
|
10K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Appendix 4E & Annual Report
|
|
philby
|
54 |
10K |
4 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
54
|
10K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Appendix 4E & Annual Report
|
|
philby
|
54 |
10K |
7 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
54
|
10K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Pipeline Update Following Strategic Portfolio Review
|
|
philby
|
204 |
34K |
1 |
13/08/22 |
13/08/22 |
ASX - By Stock
|
204
|
34K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Pipeline Update Following Strategic Portfolio Review
|
|
philby
|
204 |
34K |
10 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
204
|
34K
|
10
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Pipeline Update Following Strategic Portfolio Review
|
|
philby
|
204 |
34K |
9 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
204
|
34K
|
9
|
|
Charts
|
CYP |
Re:
CYP chart
|
|
philby
|
1.9K |
581K |
9 |
29/06/22 |
29/06/22 |
Charts
|
1.9K
|
581K
|
9
|
|
Charts
|
CYP |
Re:
CYP chart
|
|
philby
|
1.9K |
581K |
8 |
28/06/22 |
28/06/22 |
Charts
|
1.9K
|
581K
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
philby
|
10K |
3.0M |
9 |
12/12/21 |
12/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
9
|
|
ASX - By Stock
|
FGH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
philby
|
6 |
1.9K |
1 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
6
|
1.9K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Technology Featured on Front Cover of Nature Medicine
|
|
philby
|
184 |
32K |
1 |
28/11/20 |
28/11/20 |
ASX - By Stock
|
184
|
32K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Technology Featured on Front Cover of Nature Medicine
|
|
philby
|
184 |
32K |
10 |
27/11/20 |
27/11/20 |
ASX - By Stock
|
184
|
32K
|
10
|
|
ASX - By Stock
|
CYP |
Re:
Mesoblast and Novartis collaboration
|
|
philby
|
148 |
23K |
10 |
21/11/20 |
21/11/20 |
ASX - By Stock
|
148
|
23K
|
10
|
|
ASX - By Stock
|
CYP |
Re:
Questions for the Board at the AGM 2020
|
|
philby
|
88 |
17K |
5 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
88
|
17K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Questions for the Board at the AGM 2020
|
|
philby
|
88 |
17K |
11 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
88
|
17K
|
11
|
|